Impairment risk arising from declines in the value of shares held for policy purposes
First written in FY2017-Q1. 13 of 24 entries say "Restated". Latest entry: FY2025.
Toyo Securities moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.
The whole theme swung hardest in 2019: 13 of 44 companies on the "Worse" side.
15 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「There were no applicable items in the consolidated fiscal year under review.」
The Company also recorded no valuation loss or impairment loss on securities due to a decline in the value of its equity holdings. - FY2022RestatedAnnual report
「The Company recorded no impairment loss in the consolidated fiscal year under review.」
Although the Company continues to explain the risk of declines in the value of strategic equity holdings and impairment losses, it recorded no impairment loss on securities in the consolidated fiscal year under review. - FY2022-Q3RestatedAnnual report
「No special loss was recorded, compared with ¥65 million in the same quarter of the previous year.」
Although the Company continues to explain the risk of impairment losses due to declines in the value of its equity holdings and other assets, it recorded no impairment loss on investment securities during the nine-month period under review. - FY2022-Q2RestatedAnnual report
「No special loss was recorded, compared with ¥57 million in the same quarter of the previous year.」
Although the Company continues to explain the risk of impairment losses due to declines in the value of its equity holdings and other assets, it recorded no impairment loss on investment securities during the six-month period under review. - FY2022-Q1RestatedAnnual report
「No special loss was recorded, compared with ¥62 million in the same quarter of the previous year.」
Although the Company continues to explain the risk of impairment losses due to declines in the value of its equity holdings and other assets, it recorded no impairment loss on investment securities in the first quarter under review. - FY2021MaterialisedAnnual report
「In addition, the Company recorded an impairment loss of ¥66 million in the consolidated fiscal year under review, mainly due to a decline in the market value of its equity holdings.」
The decline in the value of the equity holdings materialized, and an impairment loss on investment securities of ¥66 million was recorded. - FY2021-Q3MaterialisedAnnual report
「Special losses were ¥65 million due to an impairment loss on investment securities, or 867.6% of the amount recorded in the same quarter of the previous year, and net income was ¥76 million, or 20.1% of the amount recorded in the same quarter of the previous year.」
The decline in the value of the equity holdings and other assets materialized, and an impairment loss on investment securities of ¥65 million was recorded. - FY2021-Q2MaterialisedAnnual report
「Special losses were ¥57 million due to an impairment loss on investment securities, or 757.6% of the amount recorded in the same quarter of the previous year, and net income was ¥63 million, or 39.7% of the amount recorded in the same quarter of the previous year.」
The decline in the value of the equity holdings and other assets materialized, and an impairment loss on investment securities of ¥57 million was recorded. This was up from ¥4 million in the same quarter of the previous year. - FY2021-Q1MaterialisedAnnual report
「Special losses were ¥62 million due to an impairment loss on investment securities, compared with none in the same quarter of the previous year, and net income was ¥14 million, or 9.8% of the amount recorded in the same quarter of the previous year.」
The decline in the value of the equity holdings and other assets materialized, and an impairment loss on investment securities of ¥62 million was recorded, whereas none was recorded in the same quarter of the previous year. - FY2020MaterialisedAnnual report
「In addition, the Company recorded an impairment loss of ¥6 million in the consolidated fiscal year under review, mainly due to a decline in the market value of its equity holdings.」
Due to a decline in the market value of its equity holdings and other factors, an impairment loss on investment securities of ¥6 million was recorded. - FY2020-Q3MaterialisedAnnual report
「In addition, the Company recorded an impairment loss of ¥5 million during the nine-month period ended the third quarter of the consolidated fiscal year under review, due to a decline in the market value of its equity holdings.」
The decline in the market value of the equity holdings materialized, and an impairment loss of ¥5 million was recorded. - FY2020-Q2MaterialisedAnnual report
「In addition, the Company recorded an impairment loss of ¥4 million during the six-month period ended the second quarter of the consolidated fiscal year under review, due to a decline in the market value of its equity holdings.」
The decline in the market value of the equity holdings materialized, and an impairment loss of ¥4 million was recorded. - FY2020-Q1RestatedAnnual report
「No impairment loss on securities was recognized during the three months ended the first quarter.」
The Company continues to explain the risk of declines in the value of strategic equity holdings and impairment losses, but recorded no impairment loss on securities in the current quarter. - FY2019MaterialisedAnnual report
「In addition, the Company recorded an impairment loss of ¥42 million in the consolidated fiscal year under review, mainly due to a decline in the market value of its equity holdings.」
The decline in the investment value of the equity holdings materialized, and an impairment loss on investment securities of ¥42 million was recorded. - FY2019-Q3MaterialisedAnnual report
「During the nine months ended the third quarter, an investment securities valuation loss of ¥111 million was recognized.」
A decline in the investment value of strategic shareholdings and other securities occurred, and an investment securities valuation loss of ¥111 million was recognized. - FY2019-Q2RestatedAnnual report
「No impairment loss on securities was recognized during the six months ended the second quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, and no impairment loss on securities was recognized during the six months ended the second quarter. - FY2019-Q1RestatedAnnual report
「No impairment loss on securities was recognized during the three months ended the first quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, and no impairment loss on securities was recognized during the three months ended the first quarter. - FY2018RestatedAnnual report
「There were no applicable matters for the previous fiscal year (from 1 April Heisei 28 to 31 March Heisei 29) or the current fiscal year (from 1 April Heisei 29 to 31 March Heisei 30).」
The disclosure of the risk of impairment due to a decline in the value of strategic shareholdings and other securities continues, but no impairment loss on securities was recognized in the fiscal year. - FY2018-Q3RestatedAnnual report
「No impairment loss on securities was recognized during the nine months ended the third quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, but no impairment loss on securities was recognized during the nine months ended the third quarter. - FY2018-Q2RestatedAnnual report
「No impairment loss on securities was recognized during the six months ended the second quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, but no impairment loss on securities was recognized during the six months ended the second quarter. - FY2018-Q1RestatedAnnual report
「No impairment loss on securities was recognized during the three months ended the first quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, but no impairment loss on securities was recognized during the three months ended the first quarter. - FY2017-Q3RestatedAnnual report
「No impairment loss on securities was recognized during the nine months ended the third quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, but no impairment loss on securities was recognized during the nine months ended the third quarter. - FY2017-Q2No impairment loss in the current fiscal yearAnnual report
「No impairment loss on securities was recognized during the six months ended the second quarter.」
The disclosure of the risk of a decline in the value of strategic shareholdings and impairment continues, but no impairment loss was recognized during the six months ended the second quarter, compared with the ¥11 million impairment loss recognized in the first quarter. - FY2017-Q1First statedAnnual report
「The investment value of shares may decline due to a fall in market prices or deterioration in the financial condition of the issuing company. If the Group determines that a decline in investment value is other than temporary, it recognizes impairment losses on securities in accordance with its established rules. During the three months ended the first quarter, an impairment loss of ¥11 million was recognized due to a decline in the market value of shares held.」
A decline in the market value of shares held occurred, and an investment securities valuation loss of ¥11 million was recognized.